The Valley Desk

NCT02833844 · Interventional trial

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Overall registry status Completed

Phase 3

Conditions Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov